Windlas Biotech Ltd has announced the approval of their unaudited financial results for the first half of FY26 during a board meeting held on November 6, 2025, showing a consolidated net profit of Rs. (0.03) million. The meeting began at 5:00 PM and ended at 6:00 PM.